A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 1916
[Display Entries]
100 entries :
      (Publication year, Descending)
100 entries :
      (Publication year, Ascending)
all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : IgAN
Long Form : IgA nephropathy
No. Year Title Co-occurring Abbreviation
2021 A multicenter, prospective, observational study to determine association of mesangial C1q deposition with renal outcomes in IgA nephropathy. PSM
2021 A Partial Picture of the Single-Cell Transcriptomics of Human IgA Nephropathy. scRNA-seq
2021 A single-cell survey of the human glomerulonephritis. CIN, LN, MH, MN, MT, NKT, PT, scRNA-seq
2021 An evaluation of the roles of hematuria and uric acid in defining the prognosis of patients with IgA nephropathy. AKI, HU, RBCs
2021 An Interpretable Machine Learning Survival Model for Predicting Long-term Kidney Outcomes in IgA Nephropathy. SHAP
2021 Astragaloside IV Inhibits Galactose-Deficient IgA1 Secretion via miR-98-5p in Pediatric IgA Nephropathy. AS-IV, CCK-8, ELISA, Gd-IgA1, IgAV-N, MsPGN, PBMCs, VVA
2021 B cell and monocyte phenotyping: A quick asset to investigate the immune status in patients with IgA nephropathy. ADPKD, APCs, eGFR, Gd-IgA1, HC
2021 Comprehensive analysis of IgA nephropathy expression profiles: identification of potential biomarkers and therapeutic agents. ---
2021 Correlation analysis between expression of histone deacetylase 6 and clinical parameters in IgA nephropathy patients. eGFR, HDAC6
10  2021 Detection of microRNA-33a-5p in serum, urine and renal tissue of patients with IgA nephropathy. eGFR, miR
11  2021 Efficacy and safety of immunosuppressive therapies in the treatment of high-risk IgA nephropathy: A network meta-analysis. CS, CsA, ESRD, LEF, MMF, RCTs, SC
12  2021 Endotrophin, a collagen type VI-derived matrikine, reflects the degree of renal fibrosis in patients with IgA nephropathy and in patients with ANCA-associated vasculitis. AAV, CKD, COL VI, ETP
13  2021 Enhanced Bruton's tyrosine kinase activity in the kidney of patients with IgA nephropathy. BTK, ELISA, IHC, IL, MCP, pBTK, RT-PCR, TNF
14  2021 Enumerating the role of properdin in the pathogenesis of IgA nephropathy and its possible therapies. ---
15  2021 Estrogen and estrogen receptors in kidney diseases. AKI, CKD, DKD, ERs, ET-1, LN
16  2021 Expression profile of Fc receptor-like molecules in patients with IgA nephropathy. C1GALT1, FCRL, PBMCs, qRT-PCR
17  2021 Grading system utilising the total score of Oxford classification for predicting renal prognosis in IgA nephropathy. CI, HRs
18  2021 How will artificial intelligence and bioinformatics change our understanding of IgA Nephropathy in the next decade? IgA
19  2021 Identifying Information Needs of Patients With IgA Nephropathy Using an Innovative Social Media-stepped Analytical Approach. ---
20  2021 IgA nephropathy with serum ANCA positivity: case series and literature review. ANCA
21  2021 IgA vasculitis with nephritis: update of pathogenesis with clinical implications. IgAVN
22  2021 Increased Lifetime Risk of ESRD in Familial IgA Nephropathy. CI, eGFR, ESRD, HR, MG, SG
23  2021 KM55 Monoclonal Antibody Staining in IgA-Dominant Infection-Related Glomerulonephritis. Gd-IgA1, IgA-IRGN
24  2021 Long term outcome of immunoglobulin A (IgA) nephropathy: A single center experience. eGFR, ESRD, HR, IgA, IQR, NRP, TA-proteinuria
25  2021 Long-term safety and efficacy of hydroxychloroquine in patients with IgA nephropathy: a single-center experience. eGFR, HCQ
26  2021 Measurement of galactosyl-deficient IgA1 by the monoclonal antibody KM55 contributes to predicting patients with IgA nephropathy with high risk of long-term progression. CKD, Gd-IgA1
27  2021 Mesangial C3 deposition and serum C3 levels predict renal outcome in IgA nephropathy. ---
28  2021 Multimodal imaging of bilateral ischemic retinal vasculopathy associated with Berger's IgA nephropathy: case report. SS-OCTA, UWF
29  2021 Nasal-associated lymphoid tissue is the major induction site for nephritogenic IgA in murine IgA nephropathy. NALT, TLR9
30  2021 Non-immunosuppressive therapies for childhood IgA nephropathy. RAAS
31  2021 Novel urinary glycan profiling by lectin array serves as the biomarkers for predicting renal prognosis in patients with IgA nephropathy. CI, ECA, eGFR, NPA, OR
32  2021 Pre-treatment hematuria and crescents predict estimated glomerular filtration rate trajectory after methylprednisolone pulse therapy with tonsillectomy for IgA nephropathy. CI, eGFR, HPF, OR, U-RBCs
33  2021 Predictive value of sub classification of focal segmental glomerular sclerosis in Oxford classification of IgA nephropathy. ROC
34  2021 Relationship between blood neutrophil-lymphocyte ratio and renal tubular atrophy/interstitial fibrosis in IgA nephropathy patients. AUC, ESRD, NLR
35  2021 Renal deposition and clearance of recombinant poly-IgA complexes in a model of IgA nephropathy. poly-rIgA, rIgA, SA
36  2021 Rifaximin as a Potential Treatment for IgA Nephropathy in a Humanized Mice Model. MALT, pIgR, TNF-alpha
37  2021 Role of Human Mesangial-Tubular Crosstalk in Secretory IgA-Induced IgA Nephropathy. HRMC, sIgA
38  2021 Severe psoriasis presenting with rapidly progressive (crescentic) IgA-predominant glomerulonephritis. ---
39  2021 SGLT-2 inhibition in IgA nephropathy: the new standard of care? ---
40  2021 Spleen Tyrosine Kinase Inhibition Ameliorates Tubular Inflammation in IgA Nephropathy. HMC, PTECs, Syk
41  2021 Spontaneous remission in adult patients with IgA nephropathy treated with conservative therapy. eGFR, HPF, RBC
42  2021 The role of urine IgG in the progression of IgA nephropathy with a high proportion of global glomerulosclerosis. eGFR, ESRD
43  2021 The Serum Uric Acid Level Is Related to the More Severe Renal Histopathology of Female IgA Nephropathy Patients. ECP, IF, MME, TA, UA
44  2021 The Study of Angptl4-Modulated Podocyte Injury in IgA Nephropathy. DEGs
45  2021 The Utility of Assessing CD68+ Glomerular Macrophages in Assessing Endocapillary Hypercellularity in IgA Nephropathy. ---
46  2021 Using MEST-C Scores and the International Study of Kidney Disease in Children Classification to Predict Outcomes of Henoch-Schönlein Purpura Nephritis in Children. eGFR, HR, HSPN, ISKDC
47  2021 Weighted Gene Co-expression Network Analysis Reveals Different Immunity but Shared Renal Pathology Between IgA Nephropathy and Lupus Nephritis. GEO, GWAS, LN, PBMC, SLE, WGCNA
48  2020 A cross-sectional analysis of clinicopathologic similarities and differences between Henoch-Schonlein purpura nephritis and IgA nephropathy. ELISA, g-Gd-IgA1, Gd-IgA1, HSPN, RB, s-Gd-IgA1
49  2020 A New Vision of IgA Nephropathy: The Missing Link. PBMCs
50  2020 A Personalized Update on IgA Nephropathy: A New Vision and New Future Challenges. ---
51  2020 ACTH Treatment for Management of Nephrotic Syndrome: A Systematic Review and Reappraisal. ACTH, FSGS, LN, MCD, MN, MPGN, NS
52  2020 Adult primary nephrotic syndrome trends by race: a diminished frequency of focal segmental glomerulosclerosis in non-black patients. FSGS, MCD, MR, PNS
53  2020 After ten years of follow-up, no difference between supportive care plus immunosuppression and supportive care alone in IgA nephropathy. eGFR, ESKD
54  2020 Age-adjusted global glomerulosclerosis predicts renal progression more accurately in patients with IgA nephropathy. eGFR, GSG
55  2020 An Open-Label Pilot Study ofAdrenocorticotrophic Hormone intheTreatment of IgA Nephropathy atHigh Risk of Progression. ACTH, eGFR, RAAS
56  2020 Apoptosis inhibitor of macrophage as a biomarker for disease activity in Japanese children with IgA nephropathy and Henoch-Schönlein purpura nephritis. AIM, HCs, HSPN
57  2020 Association analysis of DNA methyltransferases in IgA nephropathy. DNMTs, eGFR, Gd-IgA1, PBMCs
58  2020 Association Between Galactose-Deficient IgA1 Derived From the Tonsils and Recurrence of IgA Nephropathy in Patients Who Underwent Kidney Transplantation. TE
59  2020 Association Between Serum IgG Concentrations and Prognosis in IgA Nephropathy. sIgG
60  2020 Association between the progression of IgA nephropathy and a controlled status of hypertension in the first year after diagnosis. CI, HR
61  2020 Budesonide versus systemic corticosteroids in IgA Nephropathy: A retrospective, propensity-matched comparison. IQR
62  2020 Case report on mesangial proliferative glomerulonephritis with multicentric Castleman's disease: Approach to the onset mechanism of immunoglobulin A nephropathy. Gd-IgA1, MCD
63  2020 CD71 mesangial IgA1 receptor and the progression of IgA nephropathy. HMCs
64  2020 Characterization of IgA Deposition in the Kidney of Patients with IgA Nephropathy and Minimal Change. Gd-IgA1, IgAN-MCD, MCD
65  2020 Circulating inflammation-related factors are correlated with systemic redox status in IgA nephropathy; a case-control study. Cys, PTH
66  2020 Circulating MiR-29a, Possible Use as a Biomarker for Monitoring IgA Nephropathy. ---
67  2020 Clinical and histological differences between adults and children in new onset IgA nephropathy. ---
68  2020 Clinical and prognostic significance of C1q deposition in IgAN patients-a retrospective study. ALB, eGFR, ESRD, LDL, SCr, TC
69  2020 Clinical Profile and Outcome of IgA Nephropathy from a Tertiary Care Hospital in North India. CKD, IFTA, RPGN, TMA
70  2020 Clinical Profile, Histopathological Features and Outcome of IgA Nephropathy in a Tertiary Care Hospital in India. ESRD, NRP, SNRP
71  2020 Clinical relevance of membrane attack complex deposition in children with IgA nephropathy and Henoch-Schönlein purpura. MAC
72  2020 Clinical Relevance of Serum Galactose Deficient IgA1 in Patients with IgA Nephropathy. CKD, Gd-IgA1
73  2020 Clinical Significance of Serum Galactose-Deficient IgA1 Level in Children with IgA Nephropathy. ELISA, Gd-IgA1, HCs
74  2020 Clinical Use of Complement, Inflammation, and Fibrosis Biomarkers in Autoimmune Glomerulonephritis. AAV, FSGS, GN, LN, MCP-1, MN, MPGN, TGF-beta1
75  2020 Clinicopathological significance of glomerular capillary IgA deposition in childhood IgA nephropathy. GBM, GFR
76  2020 CMIP SNPs and their haplotypes are associated with dyslipidaemia and clinicopathologic features of IgA nephropathy. CMIP, SNPs
77  2020 Combining clinical features and MEST-C score in IgA nephropathy may be a better determinant of kidney survival. ESRD
78  2020 Comparative proteomic analysis of renal proteins from IgA nephropathy model mice and control mice. HIGA
79  2020 Complement activation is associated with crescent formation in IgA nephropathy. MASP
80  2020 Corticosteroids could improve the renal outcome of IgA nephropathy with moderate proteinuria. CR, CS, ESRD, PR, SC
81  2020 Crucial Role of AIM/CD5L in the Development of Glomerular Inflammation in IgA Nephropathy. AIM, gddY
82  2020 DelCFHR3-1 influences graft survival in transplant patients with IgA nephropathy via complement-mediated cellular senescence. CKD, delCFHR3-1
83  2020 Differential expression of peptides serves as an indicator of IgA nephropathy in pediatric patients. ---
84  2020 Differential expression of transfer RNA-derived small RNAs in IgA nephropathy. GO, PBMCs, qRT-PCR, RNA-Seq, tsRNAs
85  2020 Differentiating Staphylococcus infection-associated glomerulonephritis and primary IgA nephropathy: a mass spectrometry-based exploratory study. ATN, IHC, SAGN, TGM2
86  2020 Dihydroartemisinin inhibits the proliferation of IgAN mesangial cells through the mTOR signaling pathway. aIgA1, CCK-8, DHA, HMCs, MTT
87  2020 Effect of pemafibrate, a novel selective peroxisome proliferator-activated receptor-alpha modulator (SPPARMα), on urinary protein excretion in IgA nephropathy with hypertriglyceridemia. CKD, eGFR, SPPARMalpha
88  2020 Efficacy and safety of Abelmoschus manihot for IgA nephropathy: A multicenter randomized clinical trial. AM, eGFR
89  2020 Efficacy of corticosteroid therapy for IgA nephropathy patients stratified by kidney function and proteinuria. IRR
90  2020 Elevated Endostatin Expression Is Regulated by the pIgA Immune Complex and Associated with Disease Severity of IgA Nephropathy. GECs
91  2020 Epidemiology and Pathophysiology of Glomerular C4d Staining in Native Kidney Biopsies. FSGS, GN, LN, MCD, MPGN, TMA
92  2020 Epidemiology and risk factors for progression in Chinese patients with IgA nephropathy. MAP
93  2020 Epigenome-wide association study and network analysis for IgA Nephropathy from CD19+ B-cell in Chinese Population. EWAS, FDR
94  2020 Estimated plasma osmolarity and risk of end-stage kidney disease in patients with IgA nephropathy. ESKD
95  2020 Evidences of histologic thrombotic microangiopathy and the impact in renal outcomes of patients with IgA nephropathy. CKD, KRT, TMA
96  2020 External Validation of International Risk-Prediction Models of IgA Nephropathy in an Asian-Caucasian Cohort. eGFR
97  2020 Food antigens and Transglutaminase 2 in IgA nephropathy: Molecular links between gut and kidney. CD, sCD89, TfR1, TG2
98  2020 Formalin-fixed paraffin-embedded renal biopsy tissues: an underexploited biospecimen resource for gene expression profiling in IgA nephropathy. FFPE, KLD
99  2020 Galactose-Deficient IgA1 Deposits in Clear Cell Renal Cell Carcinoma-Related Henoch-Schonlein Purpura Nephritis. Gd-IgA1, HSPN
100  2020 Genetic variants of the MIR31HG gene are related to a risk of IgA nephropathy. CI, OR